2,6-xylidine has been researched along with Inflammation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antony, R; Arita, Y; Gupta, N; Kirk, M; Park, HJ; Peltier, MR; Stecker, MM | 1 |
1 other study(ies) available for 2,6-xylidine and Inflammation
| Article | Year |
|---|---|
Effect of 2,6-xylidine (DMA) on secretion of biomarkers for inflammation and neurodevelopment by the placenta.
Topics: Aniline Compounds; Anti-Inflammatory Agents; Biomarkers; Culture Media, Conditioned; Cytokines; Escherichia coli; Estradiol; Female; Humans; Inflammation; Interleukin-10; Interleukin-1beta; Oxidative Stress; Placenta; Pregnancy; Premature Birth; Progesterone; Tumor Necrosis Factor-alpha | 2022 |